Cheri Ackerman

A leader of scientific innovation and a winner of the Emerging Women Founder Award, Cheri co-founded Concerto to reinvent humanity’s relationship with microbes. Cheri led Concerto to raise oversubscribed Seed and Series A investment rounds, fueling the company’s development of transformative microbial treatments and industry partnerships. She holds a PhD in Chemistry from UC Berkeley and completed a postdoctoral fellowship at the Broad Institute.